Education
About Us
Working with TipRanks
Follow Us
Chemomab Therapeutics (DE:2QV)
FRANKFURT:2QV
Earnings Data
Report Date
Nov 07, 2025Before Open (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
-0.03Last Year’s EPS
-0.03Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
DE:2QV Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:2QV Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 14, 2025 | €3.10 | €3.22 | +3.87% |
May 15, 2025 | €4.40 | €4.20 | -4.55% |
Mar 03, 2025 | €5.92 | €6.16 | +4.05% |
Nov 14, 2024 | €5.64 | €6.32 | +12.04% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Chemomab Therapeutics (DE:2QV) report earnings?
Chemomab Therapeutics (DE:2QV) is schdueled to report earning on Nov 07, 2025, Before Open (Confirmed).
What is Chemomab Therapeutics (DE:2QV) earnings time?
Chemomab Therapeutics (DE:2QV) earnings time is at Nov 07, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Chemomab Therapeutics stock?
The P/E ratio of Chemomab Therapeutics is N/A.
What is DE:2QV EPS forecast?
DE:2QV EPS forecast for the fiscal quarter 2025 (Q3) is -0.03.